Foresight Diagnostics Patent Issued for Minimal Residual Dis

/PRNewswire/ -- Foresight Diagnostics, Inc, a leader in cancer diagnostics and cancer relapse testing, announced today that the U.S. Patent and Trademark...

Related Keywords

Jake Chabon , Trademark Office , Linkedin , Twitter , Prnewswire Foresight Diagnostics Inc , Chief Executive Officer , Foresight Solid Tumor Recurrence Test , Chief Medical Advisor , Foresight Diagnostics ,